Share This Page
Drug Price Trends for TIOCONAZOLE-1
✉ Email this page to a colleague
Average Pharmacy Cost for TIOCONAZOLE-1
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| TIOCONAZOLE-1 6.5% OINTMENT | 70000-0357-01 | 2.41474 | GM | 2025-04-23 |
| TIOCONAZOLE-1 6.5% OINTMENT | 70000-0357-01 | 2.39376 | GM | 2025-03-19 |
| TIOCONAZOLE-1 6.5% OINTMENT | 70000-0357-01 | 2.36339 | GM | 2025-02-19 |
| TIOCONAZOLE-1 6.5% OINTMENT | 70000-0357-01 | 2.35456 | GM | 2025-01-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Tioconazole-1
Introduction to Tioconazole-1
Tioconazole-1 is an antifungal medication commonly used to treat vaginal yeast infections. It belongs to the class of vaginal anti-infectives and is available in various forms, including a 6.5% vaginal ointment with a pre-filled applicator[2][4][5].
Market Context: Vulvovaginal Candidiasis Treatment
The global vulvovaginal candidiasis (VVC) treatment market is significant and growing. In 2021, this market was valued at USD 986.5 million and is expected to grow at a compound annual growth rate (CAGR) of 4.39% from 2022 to 2030, reaching USD 1.64 billion by 2030[1].
Segmentation and Market Share
Drug Class
Tioconazole, along with other antifungal drugs like fluconazole, clotrimazole, and ketoconazole, plays a crucial role in the VVC treatment market. Fluconazole dominated the market in 2021 with a share of 45.74%, but other drugs like tioconazole are also popular due to their efficacy and convenience[1].
Route of Administration
The oral segment dominates the VVC treatment market, but topical treatments like tioconazole are also in high demand. The oral segment accounted for more than 42.30% of the total revenue in 2021, while the topical segment is expected to grow steadily during the forecast period[1].
Price Analysis
The cost of tioconazole topical 6.5% vaginal ointment with an applicator varies slightly depending on the pharmacy. Here are some key price points:
- Current Pricing: The cost is around $16 for a supply of 4.6 grams, with prices ranging from $15.50 to $16 depending on the pharmacy and any available discounts or coupons[2][5].
- Discounts and Coupons: There are various discounts, copay cards, and rebates available that can reduce the cost for consumers. These offers can be found through websites, medical professionals, or pharmacy discount cards[2].
Market Growth Drivers
Several factors contribute to the growth of the market for antifungal drugs like tioconazole:
- Increasing Disease Prevalence: VVC affects around 138 million women annually worldwide, with 75% of women experiencing the infection at least once in their lifetime. Complicated and recurrent cases also drive the demand for effective treatments[1].
- Rising Antibiotic Resistance: The increasing prevalence of antibiotic resistance and the growing number of diabetic patients further exacerbate the need for antifungal treatments[1].
- New Approvals and Launches: Recent approvals of new therapies, such as BREXAFEMME and VIVJOA, and the launch of new drugs are driving industry growth[1].
Geographical Market
The global VVC treatment market is segmented into several regions, with North America dominating the market in 2021, accounting for more than 37.50% of the overall revenue. The Asia Pacific region is expected to witness the fastest growth rate due to rising disease burden and increasing testing rates[1].
Consumer Awareness and Healthcare Expenditure
Increased patient awareness, higher healthcare expenditure, and proactive government measures in regions like North America contribute significantly to the market growth. In the Asia Pacific, government healthcare benefits and increased consumer awareness are driving the demand for antifungal treatments[1].
Competitive Landscape
The antifungal drugs market, including tioconazole, is competitive with several major players. The market is also influenced by the growing popularity of over-the-counter (OTC) antifungal drugs, which includes products like clotrimazole, econazole, and ketoconazole[3].
Future Outlook
Given the increasing prevalence of VVC and the growing demand for effective antifungal treatments, the market for tioconazole-1 is expected to remain robust. Here are some key projections:
- Price Stability: Prices for tioconazole-1 are likely to remain stable or see minor adjustments based on market competition and the availability of discounts and coupons.
- Market Expansion: The market is expected to expand due to the rising disease burden and the introduction of new therapeutic options.
- Regional Growth: The Asia Pacific region is anticipated to show significant growth, driven by increasing awareness and healthcare improvements.
Key Takeaways
- Market Size and Growth: The global VVC treatment market is valued at USD 986.5 million in 2021 and is expected to grow to USD 1.64 billion by 2030.
- Price Points: Tioconazole-1 costs around $16 for a 4.6-gram supply, with potential discounts available.
- Market Drivers: Increasing disease prevalence, rising antibiotic resistance, and new drug approvals drive market growth.
- Geographical Dominance: North America currently dominates the market, but the Asia Pacific region is expected to grow rapidly.
Frequently Asked Questions (FAQs)
1. What is the current market size of the vulvovaginal candidiasis treatment market? The global vulvovaginal candidiasis treatment market was valued at USD 986.5 million in 2021[1].
2. How is the market for tioconazole-1 expected to grow? The market is expected to grow at a CAGR of 4.39% from 2022 to 2030, driven by increasing disease prevalence and new drug approvals[1].
3. What is the typical cost of tioconazole-1? The cost is around $16 for a 4.6-gram supply of tioconazole 6.5% vaginal ointment with an applicator[2][5].
4. Which region dominates the VVC treatment market? North America currently dominates the market, accounting for more than 37.50% of the overall revenue in 2021[1].
5. What factors contribute to the growth of the antifungal drugs market? Factors include increasing disease prevalence, rising antibiotic resistance, new drug approvals, and growing consumer awareness[1][3].
Cited Sources:
- Grand View Research: Vulvovaginal Candidiasis Treatment Market Size Report, 2030.
- Drugs.com: Tioconazole topical Prices, Coupons, Copay Cards & Patient Assistance.
- Mordor Intelligence: Antifungal Drugs Market Size & Share Analysis - Growth Trends.
- DailyMed: TIOCONAZOLE 1 - tioconazole ointment.
- Mayo Clinic Store: Leader Tioconazole 1 Vaginal Anti-Fungal.
More… ↓
